100 related articles for article (PubMed ID: 10406909)
1. AlphaIFN-induced hematologic and cytogenetic remission in chronic eosinophilic leukemia with t(1;5).
Luciano L; Catalano L; Sarrantonio C; Guerriero A; Califano C; Rotoli B
Haematologica; 1999 Jul; 84(7):651-3. PubMed ID: 10406909
[TBL] [Abstract][Full Text] [Related]
2. Clinical and cytogenetic remission induced by interferon-alpha in a patient with chronic eosinophilic leukemia associated with a unique t(3;9;5) translocation.
Yamada O; Kitahara K; Imamura K; Ozasa H; Okada M; Mizoguchi H
Am J Hematol; 1998 Jun; 58(2):137-41. PubMed ID: 9625582
[TBL] [Abstract][Full Text] [Related]
3. Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: complete haematological and cytogenetic remission induced by interferon-alpha in a case with a unique chromosomal abnormality.
Malbrain ML; Van den Bergh H; Zachée P
Br J Haematol; 1996 Jan; 92(1):176-83. PubMed ID: 8562393
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic leukemia associated with t(2;5)(p23;q31).
Lepretre S; Jardin F; Buchonnet G; Lenain P; Stamatoullas A; Kupfer I; Courville P; Callat MP; Contentin N; Bastard C; Tilly H
Cancer Genet Cytogenet; 2002 Mar; 133(2):164-7. PubMed ID: 11943346
[TBL] [Abstract][Full Text] [Related]
5. Interferon alpha induces a good molecular response in a patient with chronic eosinophilic leukemia (CEL) carrying the JAK2V617F point mutation.
Helbig G; Stella-Holowiecka B; Majewski M; Lewandowska M; Holowiecki J
Haematologica; 2007 Nov; 92(11):e118-9. PubMed ID: 18024388
[TBL] [Abstract][Full Text] [Related]
6. Chronic eosinophilic leukemia with t(6;11)(q27;q23) translocation.
Suzuki S; Chiba K; Toyoshima N; Kurosawa M; Hashino S; Musashi M; Asaka M
Ann Hematol; 2001 Sep; 80(9):553-6. PubMed ID: 11669308
[TBL] [Abstract][Full Text] [Related]
7. Molecular diagnosis and targeted therapy of a pediatric chronic eosinophilic leukemia patient carrying TPM3-PDGFRB fusion.
Li Z; Yang R; Zhao J; Yuan R; Lu Q; Li Q; Tse W
Pediatr Blood Cancer; 2011 Mar; 56(3):463-6. PubMed ID: 21072821
[TBL] [Abstract][Full Text] [Related]
8. Restoration of Th1 cytokine synthesis by T cells of patients with chronic myelogenous leukemia in cytogenetic and hematologic remission with interferon-alpha.
Reuben JM; Lee BN; Johnson H; Fritsche H; Kantarjian HM; Talpaz M
Clin Cancer Res; 2000 May; 6(5):1671-7. PubMed ID: 10815885
[TBL] [Abstract][Full Text] [Related]
9. A novel acquired cryptic three-way translocation t(2;11;5)(p21.3;q13.5;q23.2) with a submicroscopic deletion at 11p14.3 in an adult with hypereosinophilic syndrome.
Kjeldsen E
Exp Mol Pathol; 2015 Aug; 99(1):50-5. PubMed ID: 25962659
[TBL] [Abstract][Full Text] [Related]
10. Chronic clonal myeloproliferative disease associated with a t(5;21) translocation. Complete but transient hematologic and cytogenetic remission induced by interferon-alpha.
Marmont AM; Sessarego M
Leukemia; 1995 Jun; 9(6):977-80. PubMed ID: 7596188
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of cytogenetic response in Ph+ chronic myeloid leukemia patients treated with interferon alpha].
Hong H; Qiu JY; Lai YY; Shi Y; He Q; Dang H; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):269-73. PubMed ID: 12844411
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic leukaemia with a t(2;5) (p23;q35) translocation.
Sato H; Danbara M; Tamura M; Morita M
Br J Haematol; 1994 Jun; 87(2):404-6. PubMed ID: 7947287
[TBL] [Abstract][Full Text] [Related]
13. FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib.
Wang LN; Pan Q; Fu JF; Shi JY; Jin J; Li JM; Hu J; Zhao WL; Chen Z; Chen SJ
Chin Med J (Engl); 2008 May; 121(10):867-73. PubMed ID: 18706197
[TBL] [Abstract][Full Text] [Related]
14. Chronic eosinophilic leukemia with erythroblastic proliferation and the rare translocation t(8;9)(p22;p24) with PCM1-JAK2 fusion gene: a distinct clinical, pathological and genetic entity with potential treatment target?
Prochorec-Sobieszek M; Nasiłowska-Adamska B; Borg K; Kopeć I; Kos-Zakrzewska K; Juszczyński P; Warzocha K
Leuk Lymphoma; 2012 Sep; 53(9):1824-7. PubMed ID: 22288769
[No Abstract] [Full Text] [Related]
15. A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).
Iriyama N; Takahashi H; Naruse H; Miura K; Uchino Y; Nakagawa M; Iizuka K; Hamada T; Hatta Y; Nakayama T; Takei M
Mol Genet Genomic Med; 2019 Apr; 7(4):e00591. PubMed ID: 30697976
[TBL] [Abstract][Full Text] [Related]
16. Case of chronic eosinophilic leukemia with deletion of chromosome 16 and hepatitis C.
Kamineni P; Baptiste A; Hassan M; Dawkins FW; Zaidi S; Tefferi A; Lindsey M; Taddesse-Heath L
J Natl Med Assoc; 2006 Aug; 98(8):1356-60. PubMed ID: 16916138
[TBL] [Abstract][Full Text] [Related]
17. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
18. Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration.
Schöffski P; Ganser A; Pascheberg U; Büsche G; Gaede B; Hertenstein B
Ann Hematol; 2000 Feb; 79(2):95-8. PubMed ID: 10741923
[TBL] [Abstract][Full Text] [Related]
19. Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene.
Walz C; Curtis C; Schnittger S; Schultheis B; Metzgeroth G; Schoch C; Lengfelder E; Erben P; Müller MC; Haferlach T; Hochhaus A; Hehlmann R; Cross NC; Reiter A
Genes Chromosomes Cancer; 2006 Oct; 45(10):950-6. PubMed ID: 16845659
[TBL] [Abstract][Full Text] [Related]
20. Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/PCM1-JAK2-positive chronic eosinophilic leukemia.
Lierman E; Selleslag D; Smits S; Billiet J; Vandenberghe P
Blood; 2012 Aug; 120(7):1529-31. PubMed ID: 22899477
[No Abstract] [Full Text] [Related]
[Next] [New Search]
